Mindfulness may lower blood pressure in black women caring for loved ones with dementia

NCT ID NCT05721482

Completed Disease control Sponsor: Ohio State University Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This pilot study tested a telehealth program combining mindfulness, relaxation, and dietary advice (MIM-DASH) in 28 African American women over 40 who care for a family member with Alzheimer's and have high blood pressure. The goal was to see if the program could reduce stress and improve blood pressure control. Participants attended eight weekly group sessions online. The study measured changes in blood pressure, heart rate, and stress management practices.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Mindfulness-based stress reduction and dietary counseling (MIM-DASH)
What this could lead to: If successful, this approach could offer a practical, low-cost way to help Black female caregivers manage stress and control blood pressure, potentially reducing their risk of heart disease.
What could go wrong: This was a very small pilot study (28 participants) with no control group, so results may not apply broadly. The program requires time and commitment, and long-term benefits are unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPERTENSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hypertensive disorder Stress, Psychological

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HYPERTENSION STRESS, PSYCHOLOGICAL

Contacts and locations

Locations

College of Nursing Ohio State University

Columbus, Ohio, 43210, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.